SPNE News and Press, SeaSpine Holdings Corporation From 04/21/21

CARLSBAD, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release first quarter financial results after the close of...

SeaSpine (SPNE) has started a limited launch of its 3D-printed WaveForm TO (TLIF Oblique) Interbody System.The technology is designed for both posterior lumbar interbody fusion ("PILF") and transforaminal lumbar interbody fusion ("TLIF") procedures.WaveForm TO is SeaSpine's third 3D-printed i...

CARLSBAD, Calif., April 19, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its 3D-printed WaveForm TO (TLIF Obliq...

SeaSpine Holdings (SPNE) has priced its public offering of 4.5M common shares at $19.50/share, for expected gross proceeds of ~$87.8M.Underwriters' over-allotment is an additional 675K shares. Net proceeds will be used to finance the acquisition of 7D Surgical and for general corporate purpos...

Gainers: [[PGNY]] +7.9%. [[XELB]] +7.0%. [[IDYA]] +6.9%. [[LSCC]] +6.6%. [[DKNG]] +6.0%.Losers: [[SPNE]] -3.8%. [[DBVT]] -3.4%. [[SYBX]] -3.0%. [[SESN]] -2.6%. [[DSEY]] -2.5%. For further details see: PGNY, XELB, SPNE and SYBX among after-hours movers

SeaSpine (SPNE) trades 9.2% down after hours on commencing an underwritten public offering of shares; underwriters granted 30-day option to purchase up to an additional 15% of the shares.Offer size, terms not yet disclosed.Net proceeds along with its existing cash and equivalents wi...

Lilly's recent setback provide buying opportunityAlthough Eli Lilly's (LLY) share price has been hit since reporting after the bell on Tuesday that the FDA is extending the review of an sNDA for Olumiant (baricitinib) in atopic dermatitis, Cantor Fitzgerald indicates this has provided a buyin...

Gainers: Brooklyn ImmunoTherapeutics (BTX) +45%, Greenwich LifeSciences (GLSI) +16%, PAVmed (PAVM) +15%, SeaSpine Holdings (SPNE) +14%, Cara Therapeutics (CARA) +14%.Losers: Scholar Rock (SRRK) -14%, Chembio Diagnostics (CEMI) -13%, Harmo...

SeaSpine Holdings (SPNE) sees Q1 revenue in the range of $41.5M-42.0M vs. a consensus of $39.22M.For full-year 2021, total revenue to be in the range of $193M-$198M vs. a consensus of $185.77M. The guidance does not include the pending acquisition of 7D Surgical.Cash, cash equivalents, and in...

CARLSBAD, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the first quarter of 2021 and provide...